Cingulate (CING) Common Equity (2020 - 2026)
Cingulate's Common Equity came in at $23.47 million for Q2 2026, up 325.8% from $5.51 million a year earlier.
Powered by 
Analysis
Cingulate (CING) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Cingulate's Common Equity was $2.51 million, down 66.3% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 14.2% (FY2020 to FY2025).
- Going back by year, Common Equity was $7.46 million in FY2024, -$6.87 million in FY2023, $3.88 million in FY2022 (-81.4%) and $20.84 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Common Equity in data going back to Q4 2020.
- Year-over-year, Common Equity increased in three of the last five quarters, with growth averaging 70.3%.
- The fastest year-over-year change in Common Equity over five years came in Q2 2022 (growth of 541.5%), and the weakest in Q1 2023 (a decline of 99.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Cingulate | 63.03 Mn | -8.35 Mn | - | 23.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.47 Mn |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 3.47 Mn |
| Jun 30, 2025 | 5.51 Mn |
| Mar 31, 2025 | 5.93 Mn |
| Dec 31, 2024 | 7.46 Mn |
| Sep 30, 2024 | 12.04 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 3.22 Mn |
| Dec 31, 2023 | -6.87 Mn |
| Sep 30, 2023 | -96,334.00 |
| Jun 30, 2023 | -6.10 Mn |
| Mar 31, 2023 | 81,614.00 |
| Dec 31, 2022 | 3.88 Mn |
| Sep 30, 2022 | 8.37 Mn |
| Jun 30, 2022 | 12.18 Mn |
| Mar 31, 2022 | 16.02 Mn |
| Dec 31, 2021 | 20.84 Mn |
| Sep 30, 2021 | 3.08 Mn |
| Jun 30, 2021 | 1.90 Mn |
API Access
Cingulate Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CING&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CING", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CING&period=max&api_key=YOUR_API_KEY");
const data = await res.json();